Actively Recruiting
Cryotherapy in the Treatment of Desmoid Tumors
Led by Istituto Ortopedico Rizzoli · Updated on 2025-08-01
94
Participants Needed
1
Research Sites
293 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.
CONDITIONS
Official Title
Cryotherapy in the Treatment of Desmoid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologic diagnosis of desmoid tumors
- Age over 18 years
- Abdominal and extra-abdominal desmoid tumors
You will not qualify if you...
- Contraindication to the procedure due to tumor proximity to neurologic or vascular structures
- Retroperitoneal desmoid tumors
- Age under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Itituto Ortopedico Rizzoli
Bologna, BO, Italy, 40136
Actively Recruiting
Research Team
C
Costantino Errani, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here